QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ABUS

QT69Arbutus Biopharma Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
4.55
+0.12+2.71%
OverviewShort InterestFilings
ABUSQT69Arbutus Biopharma Corporation·NASDAQ
OverviewShort InterestFilings
4.55+2.71%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 10, 2026Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 2026Jun 10, 20264Statement of changes in beneficial ownership
Jun 05, 2026Jun 05, 2026S-8Registration of employee benefit securities
May 27, 2026May 27, 20268-KCurrent report
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 13, 2026May 13, 202610-QQuarterly report
May 13, 2026May 13, 20268-KCurrent report
Apr 28, 2026Apr 28, 2026SC 13D/ASC 13D/A
Apr 15, 2026Apr 15, 20268-KCurrent report
Apr 14, 2026Apr 14, 2026DEF 14ADefinitive proxy statement
Apr 14, 2026Apr 14, 2026DEFA14AAdditional proxy soliciting materials
Apr 13, 2026Apr 13, 2026SC 13D/ASC 13D/A
Mar 23, 2026Mar 23, 20268-KCurrent report
Mar 23, 2026Mar 23, 202610-KAnnual report
Mar 03, 2026Mar 03, 20268-KCurrent report
Feb 20, 2026Feb 20, 20268-KCurrent report
Feb 17, 2026Feb 17, 2026SC 13G/ASC 13G/A
Feb 11, 2026Feb 11, 2026SC 13G/ASC 13G/A
Feb 06, 2026Feb 06, 20268-KCurrent report
Feb 02, 2026Feb 02, 20264Statement of changes in beneficial ownership
Feb 02, 2026Feb 02, 20264Statement of changes in beneficial ownership
Jan 16, 2026Jan 16, 20268-KCurrent report
Dec 11, 2025Dec 11, 20258-KCurrent report
Nov 13, 2025Nov 13, 202510-QQuarterly report
Nov 13, 2025Nov 13, 20258-KCurrent report
#1 / 25 of 232
Page
▼
/ 10